{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:47:50Z","timestamp":1764510470456},"reference-count":27,"publisher":"Elsevier BV","issue":"12","content-domain":{"domain":["lrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.leukres.2013.07.021","type":"journal-article","created":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T22:58:24Z","timestamp":1376089104000},"page":"1612-1615","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes"],"prefix":"10.1016","volume":"37","author":[{"given":"Jaroslav","family":"Cermak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Jonasova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Vondrakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libor","family":"Cervinek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Belohlavkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radana","family":"Neuwirtova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2013.07.021_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0145-2126(00)00100-4","article-title":"Best supportive care for the anaemia of myelodysplasia: inclusion of recombinant erythropoietin therapy","volume":"25","author":"Bowen","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2013.07.021_bib0010","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.leukres.2009.06.033","article-title":"Impact of transfusion dependency on survival in patients with early myelodysplastic syndrome without excess of blasts","volume":"33","author":"Cermak","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2013.07.021_bib0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000203949","article-title":"Use of iron chelators in preventing hydroxyl radical damage: adult respiratory distress syndrome as an experimental model for the pathophysiology and treatment of oxygen-radical-mediated tissue damage","volume":"95","author":"Marx","year":"1996","journal-title":"Acta Haematol"},{"key":"10.1016\/j.leukres.2013.07.021_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-010-1091-1","article-title":"Iron overload in MDS\u2013pathophysiology, diagnosis and complications","volume":"80","author":"Gattermann","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.leukres.2013.07.021_bib0025","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(87)90545-9","article-title":"1-2-dimethyl-3-hydroxypyrid-4-one an orally active chelator for treatment of iron overload","volume":"329","author":"Kontoghiorghes","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2013.07.021_bib0030","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJM199504063321404","article-title":"Iron-chelation therapy with oral deferiprone in patients with thalassemia major","volume":"332","author":"Olivieri","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2013.07.021_bib0035","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1600-0609.1994.tb01323.x","article-title":"Deferiprone-associated myelotoxicity","volume":"53","author":"Al-Refaie","year":"1994","journal-title":"Eur J Haematol"},{"issue":"Suppl. A","key":"10.1016\/j.leukres.2013.07.021_bib0040","first-page":"143","article-title":"Iron overload in polytransfused patients with MDS: use of L1 for oral iron chelation","volume":"28","author":"Jaeger","year":"1992","journal-title":"Drugs Today"},{"key":"10.1016\/j.leukres.2013.07.021_bib0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-0609.2007.00985.x","article-title":"Relative response of patiens with myelodysplastic syndromes and other transfusion- dependent anemias to deferasirox (ICL670): a 1-yr prospective study","volume":"80","author":"Porter","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2013.07.021_bib0050","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.leukres.2010.03.009","article-title":"Deferasirox in ironoverloaded patients with transfusion-dependent myelodysplastic syndromes: results from the large 1-year EPIC study","volume":"34","author":"Gattermann","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2013.07.021_bib0055","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.021_bib0060","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.021_bib0065","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","article-title":"Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria, a basis for clinical decision making","volume":"23","author":"Malcovati","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2013.07.021_bib0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2141.2003.03907.x","article-title":"Guidelines for the diagnosis nad therapy of adult myelodysplastic syndromes","volume":"120","author":"Bowen","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2013.07.021_bib0075","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2006.08.5696","article-title":"Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes","volume":"25","author":"Malcovati","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2013.07.021_bib0080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11899-011-0084-z","article-title":"The relevance of iron overload and the appropriateness of iron chelation therapy for patiens with myelodysplastic syndromes: a dialogue and debate","volume":"6","author":"Steensma","year":"2011","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.leukres.2013.07.021_bib0085","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.leukres.2009.12.004","article-title":"Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients?. A multicenter study by the GFM","volume":"34","author":"Rose","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2013.07.021_bib0090","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/blood.V112.11.640.640","article-title":"Independent impact of iron overload and transfusion dependency on survival and leukemic evolution in patients with myelodysplastic syndrome","volume":"112","author":"Sanz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.021_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2010.09.003","article-title":"Controversies surrounding chelation therapy for MDS","volume":"25","author":"Leitch","year":"2011","journal-title":"Blood Rev"},{"key":"10.1016\/j.leukres.2013.07.021_bib0100","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1182\/blood-2006-10-054924","article-title":"Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation","volume":"109","author":"Armand","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.021_bib0105","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1182\/blood-2006-02-002394","article-title":"Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia: new data, new questions","volume":"107","author":"Neufeld","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.021_bib0110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","article-title":"Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance","volume":"127","author":"Anderson","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2013.07.021_bib0115","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/blood-2005-08-3430","article-title":"A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia","volume":"107","author":"Cappellini","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.07.021_bib0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/08880018.2012.762568","article-title":"Comparative assessment of deferiprone and deferasirox in thalassemia major patients in the first two decades\u2013single center experience","volume":"30","author":"Zachariah","year":"2013","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.leukres.2013.07.021_bib0125","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3324\/haematol.2011.048546","article-title":"Hematologic responses with deferasirox therapy in transfusion-dependent myelodysplastic syndromes patients","volume":"97","author":"Gattermann","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2013.07.021_bib0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/03630260500455375","article-title":"Erythropoietin administration may potentiate mobilization of iron stores in patients on iron chelation therapy","volume":"30","author":"Cermak","year":"2006","journal-title":"Hemoglobin"},{"key":"10.1016\/j.leukres.2013.07.021_bib0135","doi-asserted-by":"crossref","first-page":"a011668","DOI":"10.1101\/cshperspect.a011668","article-title":"Iron metabolism: interaction with normal and disordered erythropoiesis","volume":"2","author":"Ganz","year":"2012","journal-title":"Cold Spring Harb Perspect Med"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613002488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613002488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T09:52:13Z","timestamp":1715853133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212613002488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0145212613002488"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2013.07.021","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2013.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}